Coumadin-induced skin necrosis of the breasts: case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21629052.
- Also identified by DOI 10.1097/SAP.0b013e31821ee41c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case report of coumadin-induced skin necrosis (CISN) is presented, followed by a topic review of CISN, which reviews presentation, pathophysiology, differential diagnosis, prevention, and management of this disorder. The prevalence of CISN is low (0.01%-0.1% of patients receiving coumadin). However, of those affected, over 50% required some form of surgical debridement or reconstruction. Although skin necrosis secondary to coumadin therapy is rare, it is essential for plastic surgeons to be aware of this clinical entity in order to make the correct diagnosis and provide appropriate treatment.
Medical subject headings
- Anticoagulants
- Breast Diseases
- Warfarin